Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

32.88 +0.07 (+0.21%)

Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,430,728
Open	32.91
Bid (Size)	28.70 (100)
Ask (Size)	38.77 (100)
Prev. Close	32.81
Today's Range	32.42 - 32.92
52wk Range	23.69 - 38.79
Shares Outstanding	N/A
Dividend Yield	1.82%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Smith & Nephew PLC (NYSE:SNN): A Value Investment in Medical Devices ↗

November 29, 2025

Smith & Nephew (SNN) is a value investment in medical devices, with strong profitability, accelerating growth, and attractive valuation metrics.

Via Chartmill

Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

October 27, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Performance

YTD	N/A	N/A
1 Month	-0.2%	-0.2%
3 Month	-9.5%	-9.5%
6 Month	+9.8%	+9.8%
1 Year	+34.8%	+34.8%

More News

UFC® and Smith+Nephew announce multi-year extension of partnership

October 22, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?

October 17, 2025

Via MarketMinute

Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

October 09, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention

October 03, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

October 01, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗

September 25, 2025

Via Benzinga

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

September 11, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

What Does the Market Think About Smith & Nephew? ↗

September 03, 2025

Via Benzinga

Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System

September 03, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Sterling Infrastructure Posts Better-Than-Expected Earnings, Joins Lemonade, DigitalOcean Holdings, Lattice Semiconductor And Other Big Stocks Moving Higher On Tuesday ↗

August 05, 2025

Via Benzinga

Top 2 Health Care Stocks You May Want To Dump In Q3 ↗

August 05, 2025

Via Benzinga

Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗

August 05, 2025

Via Benzinga

Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

July 07, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair

June 29, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures

June 24, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

June 23, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

June 18, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

June 09, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

May 27, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

A comparative sNPWT study of 10,000+ C-sections shows PICO™ sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients

May 14, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

May 07, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

March 12, 2025

Via Benzinga

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

March 11, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Frequently Asked Questions

Is Smith & Nephew SNATS, Inc. Common Stock publicly traded?

Yes, Smith & Nephew SNATS, Inc. Common Stock is publicly traded.

What exchange does Smith & Nephew SNATS, Inc. Common Stock trade on?

Smith & Nephew SNATS, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Smith & Nephew SNATS, Inc. Common Stock?

The ticker symbol for Smith & Nephew SNATS, Inc. Common Stock is SNN on the New York Stock Exchange

What is the current price of Smith & Nephew SNATS, Inc. Common Stock?

The current price of Smith & Nephew SNATS, Inc. Common Stock is 32.88

When was Smith & Nephew SNATS, Inc. Common Stock last traded?

The last trade of Smith & Nephew SNATS, Inc. Common Stock was at 01/02/26 07:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.